Search Results - "Swahn, Marie"
-
1
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
Published in The Journal of biological chemistry (30-11-2012)“…β-Site amyloid precursor protein cleaving enzyme1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and…”
Get full text
Journal Article -
2
Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
Published in Journal of neurochemistry (01-08-2010)“…J. Neurochem. (2010) 114, 784-794. Positron emission tomography (PET) radioligands that bind selectively to β-amyloid plaques (Aβ) are promising imaging tools…”
Get full text
Journal Article -
3
Video Radiology Reports: A Valuable Tool to Improve Patient-Centered Radiology
Published in American journal of roentgenology (1976) (01-09-2022)“…Improved communication between radiologists and patients is a key component of patient-centered radiology. The purpose of this study was to create…”
Get full text
Journal Article -
4
Radiosynthesis of the candidate β-amyloid radioligand [11C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys
Published in Synapse (New York, N.Y.) (01-10-2010)“…β‐Amyloid accumulation is associated with the pathogenesis of Alzheimer's disease (AD). AZD2184, a new radioligand for high‐contrast positron emission…”
Get full text
Journal Article -
5
Decreased Tongue Volume Post Radiation
Published in Annals of otology, rhinology & laryngology (01-08-2020)“…Objectives: To evaluate volume changes within the tongue post chemoradiation therapy (CRT) Study Design: Retrospective review Setting: Academic Medical Center…”
Get full text
Journal Article -
6
New Aminoimidazoles as β‑Secretase (BACE-1) Inhibitors Showing Amyloid‑β (Aβ) Lowering in Brain
Published in Journal of medicinal chemistry (08-11-2012)“…Amino-2H-imidazoles are described as a new class of BACE-1 inhibitors for the treatment of Alzheimer’s disease. Synthetic methods, crystal structures, and…”
Get full text
Journal Article -
7
Design and Synthesis of β‑Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β‑Amyloid Peptides
Published in Journal of medicinal chemistry (08-11-2012)“…The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clinical…”
Get full text
Journal Article -
8
Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules
Published in Bioorganic & medicinal chemistry letters (01-10-2011)“…A valid PLS-DA model to predict attrition in pre-clinical toxicology for basic oral candidate drugs was built. A combination of aromatic/aliphatic balance,…”
Get full text
Journal Article -
9
AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice
Published in The Journal of neuroscience (12-06-2013)“…Aβ, the product of APP (amyloid precursor protein), has been implicated in the pathophysiology of Alzheimer's disease (AD). β-Site APP cleaving enzyme1 (BACE1)…”
Get full text
Journal Article -
10
Creation of Novel Cores for β‑Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy
Published in ACS medicinal chemistry letters (10-04-2014)“…In order to find optimal core structures as starting points for lead optimization, a multiparameter lead generation workflow was designed with the goal of…”
Get full text
Journal Article -
11
Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3
Published in Bioorganic & medicinal chemistry letters (01-03-2006)“…The design and synthesis of new c-Jun N-terminal kinase-3 inhibitors (JNK3) with selectivity against JNK1 and p38α are reported. Compound 18 displayed the best…”
Get full text
Journal Article -
12
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients
Published in European journal of nuclear medicine and molecular imaging (2013)“…Purpose The aim of this study was to evaluate AZD2995 side by side with AZD2184 as novel PET radioligands for imaging of amyloid-β in Alzheimer’s disease (AD)…”
Get full text
Journal Article -
13
Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3
Published in Bioorganic & medicinal chemistry letters (15-11-2005)“…The structure-based design and synthesis of a new series of c-Jun N-terminal kinase-3 inhibitors 4 with selectivity against JNK1 and p38α is reported. The…”
Get full text
Journal Article -
14
Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy
Published in Bioorganic & medicinal chemistry letters (01-03-2012)“…The evaluation of a series of bicyclic aminoimidazoles as potent BACE-1 inhibitors is described. The crystal structures of compound 14 and compound 23 in…”
Get full text
Journal Article -
15
Liver X receptor agonists with selectivity for LXRβ; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides
Published in Bioorganic & medicinal chemistry letters (01-04-2009)“…The synthesis and SAR of a new series of LXR agonist is reported. The N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methyl-propionamide hits were found in a limited…”
Get full text
Journal Article -
16
Recent Progress in the Discovery of Kv7 Modulators
Published in Annual Reports in Medicinal Chemistry (2011)Get full text
Book Chapter -
17
A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation
Published in International journal of oncology (01-03-2012)“…The purpose of this study was to assess the response rate, toxicity, progression-free survival (PFS) and overall survival (OS) in a series of advanced stage…”
Get full text
Journal Article -
18
Phase II study of docetaxel weekly in combination with carboplatin every 3 weeks as first-line chemotherapy in stage IIB to stage IV epithelial ovarian cancer
Published in International journal of gynecological cancer (01-01-2012)“…The purpose of this study was to assess the response rate, toxicity, progression-free survival, and overall survival in a series of patients with…”
Get more information
Journal Article -
19
New heteroaryl-spaced phosphono α-amino acids are competitive NMDA antagonists with analgesic activity
Published in Bioorganic & medicinal chemistry letters (23-07-1996)“…The synthesis and the NMDA receptor binding affinities of α-amino-3-(phosphonomethyl)-2-naphthalene-propanoic acid,…”
Get full text
Journal Article -
20
Two non-racemic preparations of a piperidine-based NMDA antagonist with analgesic activity
Published in Bioorganic & medicinal chemistry (01-07-1997)“…(2 R,3 S,1′ R)-3-(1-Hydroxy-2-phosphonoethyl)-2-piperidinecarboxylic acid 1 has been synthesized by two different methods. The NMDA receptor binding affinities…”
Get full text
Journal Article